ARCHIVES

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Task Force: No Routine Mammograms Until 50

November 20, 2009

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

NCAB TO Reconsider Decision Not To Fund Diet Fit Trial

October 20, 1989

“Official Chronology” Of Gall/Montagnier Finding Agreed On; Royalties to Fund AIDS research

April 10, 1987